Supernus Pharmaceuticals (SUPN) Preferred Dividend Payments (2011 - 2012)
Supernus Pharmaceuticals (SUPN) posted quarterly Preferred Dividend Payments of $286000.0 for Q2 2012, down 66.67% year-over-year from $858000.0 in Q3 2011, and down 66.67% on a QoQ basis from $858000.0 in Q1 2012.
Supernus Pharmaceuticals (SUPN) Preferred Dividend Payments (2011 - 2012) Analysis & Trends
Supernus Pharmaceuticals has reported Preferred Dividend Payments for 2 years, with the latest figure at $286000.0 in Q2 2012.
- Preferred Dividend Payments for Q2 2012 came in at $286000.0, down 66.67% year-over-year; the trailing twelve-month figure through Dec 2012 was $1.1 million (down 66.66% YoY), and the FY2012 annual result was $1.1 million, down 66.68% from the prior year.
- Preferred Dividend Payments declined to $286000.0 in Q2 2012, from $858000.0 in the prior quarter.
- Over five years, Preferred Dividend Payments peaked at $858000.0 in Q1 2011 and troughed at $286000.0 in Q2 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Supernus Pharmaceuticals | 2.75 Bn | 2.38 Bn | 185.39 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2012 | 286,000.00 |
| Mar 31, 2012 | 858,000.00 |
| Dec 31, 2011 | 857,000.00 |
| Sep 30, 2011 | 858,000.00 |
| Jun 30, 2011 | 858,000.00 |
| Mar 31, 2011 | 858,000.00 |